DNLI
Denali Therapeutics Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:46:56 AM EST
18.48USD+0.435%(+0.08)26,798
DNLI Financials
In Q3 FY 2026 (ended ), Denali Therapeutics Inc. Common Stock (DNLI) reported revenue of $17.78M, net income of $70.13M, operating cash flow of −$117.44M, and assets of $1.26B (filed ).
Loading financial statements…
